- WAY-100635
drugbox
ImageFile =
ImageSize =
IUPAC_name = "N"- [2- [4-(2-methoxyphenyl)-1-piperazinyl] ethyl] - "N"-(2-pyridyl)cyclohexanecarboxamide trihydrochloride
OtherNames =
CAS_number = 146714-97-8
PubChem=104911
SMILES=O=C(C1CCCCC1)N(CCN2CCN(c3ccccc3OC)CC2)c4ncccc4.Cl.Cl.Cl
C=25|H=37|Cl=3|N=4|O=2
molecular_weight = 531.94588WAY-100635 is an organic compound that is a potent
human dopamine receptor D4 full agonist , [Cite journal
author = Benjamin R. Chemel, Bryan L. Roth, Blaine Armbruster, Val J. Watts andDavid E. Nichols
title = WAY-100635 is a potent dopamine D4 receptor agonist
journal =Psychopharmacology
month = October
volume = 188
issue = 2
pages = 244–251.
year = 2006
pmid = 16915381
url = http://www.springerlink.com/content/vt36125287348028/
doi = 10.1007/s00213-006-0490-4] and areceptor antagonist for the serotonin-1A receptor. [Cite journal
author = C. A. Fornal, C. W. Metzler, R. A. Gallegos, S. C. Veasey, A. C. McCreary and B. L. Jacobs
title = WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135
journal =The Journal of Pharmacology and Experimental Therapeutics
volume = 278
issue = 2
pages = 752–762
year = 1996
url = http://jpet.aspetjournals.org/cgi/content/abstract/278/2/752
pmid = 8768728] It is sometimes referred to as asilent antagonist for the latter receptor. [Cite journal
author =A. Fletcher ,E. A. Forster ,D. J. Bill ,G. Brown ,I. A. Cliffe ,J. E. Hartley ,D. E. Jones ,A. McLenachan ,K. J. Stanhope ,D. J. Critchley ,K. J. Childs ,V. C. Middlefell ,L. Lanfumey ,R. Corradetti ,A. M. Laporte ,H. Gozlan ,M. Hamon &C. T. Dourish
title = Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist
journal =Behavioural Brain Research
volume = 73
issue = 1-2
pages = 337–333
year = 1996
month =
pmid = 8788530] Labeled with theradioisotope carbon-11 it is used as aradioligand inpositron emission tomography (PET) studies of the serotonin-1Aneuroreceptor in thebrain . [Cite journal
author = Victor W. Pike, Julie A. McCarron, Adriaan A. Lammerstma, Susan P. Hume, Keith Poole,Paul M. Grasby , Andrea Malizia, Ian A. Cliffe, Allan Fletcher & Christopher J. Bench
title = First delineation of 5-HT1A receptors in human brain with PET and [11C] WAY-100635
journal =European Journal of Pharmacology
volume = 283
month = September
year = 1995
pages = R1–R3
doi = 10.1016/0014-2999(95)00438-Q
unused_data = |issues 1-3 ] WAY-100635 may be labeled in different ways with carbon-11: As [carbonyl-11C] WAY-100635 or [O-methyl-11C] WAY-100635, with [carbonyl-11C] WAY-100635 regarded as "far superior". [Cite journal
author = Victor W. Pike, Julie A. McCarron, Adriaan A. Lammertsma, Safiye Osman, Susan P. Hume, Peter A. Sargent, Christopher J. Bench, Ian A. Cliffe, Alan Fletcher and Paul M. Grasby
title = Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11C] WAY-100635
journal =European Journal of Pharmacology
volume = 301
issues = 1-3
month = April
year = 1996
pages = R5–R7
doi = 10.1016/0014-2999(96)00079-9 ] Labeled withtritium WAY-100635 may also be used inautoradiography . [Cite journal
author = Susan P. Hume, Sharon Ashworth, Jolanta Opacka-Juffry, Randal G. Ahier, Adriaan A. Lammertsma, Victor W. Pike, Ian A. Cliffe, Allan Fletcher and Alan C. White
title = Evaluation of ["O-methyl"-3H] WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain
journal =European Journal of Pharmacology
volume = 271
issues = 2-3
month = December
year = 1994
pages = 515–523
doi = 10.1016/0014-2999(94)90813-3] WAY-100635 has higher selectivity and 5-HT1A affinity than8-OH-DPAT . [Cite journal
author = P. W. J. Burnet, S. L. Eastwood & P. J. Harrison
title = [3H] WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H] 8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia
journal =Neurochemistry International
year = 1997
month = June
volume = 30
issue = 6
pages = 565–574
pmid = 9152998
doi = 10.1016/S0197-0186(96)00124-6]Human PET studies
In human PET studies WAY-100635 shows high binding in the
cerebral cortex ,hippocampus ,raphe nucleus andamygdaloid nucleus , while lower inthalamus andbasal ganglia . [Cite journal
author =Hiroshi Ito ,Christer Halldin &Lars Farde
title = Localization of 5-HT1A receptors in the living human brain using carbonyl-11CWAY-100635: PET with anatomic standardization technique
journal =Journal of Nuclear Medicine
volume = 40
issue = 1
pages = 102–109
year = 1999
month = January
pmid = 9935065
url = http://jnm.snmjournals.org/cgi/content/abstract/40/1/102] One study described a case with relatively high binding in the cerebellum. [Cite journal
author =Jussi Hirvonen ,Jaana Kajander ,Topias Allonen ,Vesa Oikonen ,Kjell Nagren &Jarmo Hietala
title = Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and "carbonyl"-11CWAY-100635—considerations on the validity of cerebellum as a reference region
journal =Journal of Cerebral Blood Flow and Metabolism
volume = 27
issue = 1
pages = 185–185
year = 2007
month = January
doi = 10.1038/sj.jcbfm.9600326
pmid = 16685258]In relating its binding to subject variables one Swedish study found WAY-100635 binding in
raphe brain region correlating withself-transcendence andspiritual acceptance personality trait s.Cite journal
author = Jacqueline Borg, Bengt Andrée, Henrik Soderstrom,Lars Farde
title = The Serotonin System and Spiritual Experiences
journal =American Journal of Psychiatry
volume = 160
issue = 11
month = November
year = 2003
pages = 1965–1969
url = http://ajp.psychiatryonline.org/cgi/content/full/160/11/1965
doi = 10.1176/appi.ajp.160.11.1965] WAY-100635 binding has also been assessed in connection withclinical depression , where there has been disagreement about the presence and direction of the 5-HT1A receptor binding. [Cite journal
author =Wayne C. Drevets , Michael E. Thase, Eydie L. Moses-Kolko, Julie Price, Ellen Frank, David J. Kupfer and Chester Mathis
title = Serotonin-1A receptor imaging in recurrent depression: replication and literature review
journal =Nuclear Medicin and Biology
year = 2007
month = October
volume = 34
issue = 7
pages = 865–877
pmid = 17921037
doi = 10.1016/j.nucmedbio.2007.06.008 ] In healthy subjects WAY-100635 binding has been found to decline with age,Cite journal
author = Johannes Tauscher, N. Paul L. G. Verhoeff, Bruce K. Christensen, Doug Hussey,Jeffrey H. Meyer , Alex Kecojevic, Mahan Javanmard, Siegfried Kasper and Shitij Kapur
title = Serotonin 5-HT1A Receptor Binding Potential Declines with Age as Measured by [11C] WAY-100635 and PET
journal =Neuropsychopharmacology
volume = 24
issue = 5
month = May
year = 2001
pages = 522–530
doi = 10.1016/S0893-133X(00)00227-X] — though not all studies have found this relationship.Cite journal
author = Rabiner EA, Messa C, Sargent PA, Husted-Kjaer K, Montgomery A, Lawrence AD, Bench CJ, Gunn RN, Cowen P, Grasby PM.
title = A database of [11C] WAY-100635 binding to 5-HT1A receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variables
journal =NeuroImage
year = 2002
month = March
volume = 15
issue = 3
pages = 620–632
pmid = 11848705
doi = 10.1006/nimg.2001.0984 ] Cite journal
author = R. V. Parsey, M. A. Oquendo, N. R. Simpson, R. T. Ogden, R. Van Heertum, V. Arango V, J. J. Mann
title = Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11] WAY-100635
journal =Brain Research
year = 2002
month = November
volume = 954
issue = 2
pages = 173–182
pmid = 12414100
doi = 10.1016/S0006-8993(02)03243-2]See also
*
Binding potential
* Other ligands for the serotonin system:
**Altanserin
**DASB External links
* Cite web
url = http://www.turkupetcentre.net/analysis/doc/tracer/way100635.html
title = Quantification of (carbonyl-11C)WAY-100635 PET studies
author = Vesa Oikonen
publisher = Turku PET center
year = 2007References
Wikimedia Foundation. 2010.